Grant: Master's Award: Canada Graduate Scholarships
University of Calgary
$17,500.00
Investigating the Mechanisms Driving Fluoroquinolone-Associated Aortic Remodelling
EF 2020-21
Résumé
Fluoroquinolone antibiotics are amongst the most prescribed in the world. These drugs provide an invaluable resource to physicians against respiratory and urinary tract infections. Recent clinical studies have shown, however, that these antibiotics increase the risk of rupture and dissection of the aorta – the main artery that carries blood from the heart. Aortic rupture and dissection are catastrophic events and often results in death, and frequently do not have symptoms until it is already too late. The high usage rates of fluoroquinolones coupled with the devastating consequences of aortic rupture and dissection present a major health problem. The way in which fluoroquinolones increase risk of aortic rupture and dissection remains unclear. Thus far, studies examining fluoroquinolones and aortic disease have only focused on one specific fluoroquinolone called ciprofloxacin. These studies have found possible ways in which ciprofloxacin may break down the walls of the aorta. However, there are tens of fluoroquinolone antibiotics and ciprofloxacin is only one of these. We must then ask the question: are all fluoroquinolones harmful to the aorta? My study uses cell and animal studies to investigate if differences exist between fluoroquinolones, and their effect on the aorta. We will also study how these antibiotics cause aortic damage. By determining if some fluoroquinolones are less harmful than others, this study can optimize how physicians treat infections with this life saving class of antibiotics.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
449514
Name
Dundas Jameson
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the Mechanisms Driving Fluoroquinolone-Associated Aortic Remodelling
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Aneurysm; Antibiotics; Aorta; Aortopathy; Extracellular Matrix; Fibroblasts; Fluoroquinolones
Abstract
Fluoroquinolone antibiotics are amongst the most prescribed in the world. These drugs provide an invaluable resource to physicians against respiratory and urinary tract infections. Recent clinical studies have shown, however, that these antibiotics increase the risk of rupture and dissection of the aorta – the main artery that carries blood from the heart. Aortic rupture and dissection are catastrophic events and often results in death, and frequently do not have symptoms until it is already too late. The high usage rates of fluoroquinolones coupled with the devastating consequences of aortic rupture and dissection present a major health problem. The way in which fluoroquinolones increase risk of aortic rupture and dissection remains unclear. Thus far, studies examining fluoroquinolones and aortic disease have only focused on one specific fluoroquinolone called ciprofloxacin. These studies have found possible ways in which ciprofloxacin may break down the walls of the aorta. However, there are tens of fluoroquinolone antibiotics and ciprofloxacin is only one of these. We must then ask the question: are all fluoroquinolones harmful to the aorta? My study uses cell and animal studies to investigate if differences exist between fluoroquinolones, and their effect on the aorta. We will also study how these antibiotics cause aortic damage. By determining if some fluoroquinolones are less harmful than others, this study can optimize how physicians treat infections with this life saving class of antibiotics.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Dundas, Jameson
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~